US 6462032
Cyclic regimens utilizing indoline derivatives
expired A61KA61K31/535A61K31/56
Quick answer
US patent 6462032 (Cyclic regimens utilizing indoline derivatives) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/535, A61K31/56, A61K31/57, A61K45/06